BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19943219)

  • 1. Key Opinion Leaders - SMi's Second Conference Knowledge Leaders.
    Mason VL
    IDrugs; 2009 Dec; 12(12):770-3. PubMed ID: 19943219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMi's Conducting Clinical Trials in Europe.
    Jago C
    IDrugs; 2009 Dec; 12(12):754-9. PubMed ID: 19943216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key opinion leaders: where they come from and how that affects the drugs you prescribe.
    Meffert JJ
    Dermatol Ther; 2009; 22(3):262-8. PubMed ID: 19453351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Opinion Leaders--SMi's inaugural conference understanding physician-pharmaceutical industry relationships.
    Mason V
    IDrugs; 2008 Dec; 11(12):889-93. PubMed ID: 19051150
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

  • 7. Generics, Supergenerics and Patent Strategies--SMi's 13th Annual Meeting.
    Edwards C
    IDrugs; 2010 Jul; 13(7):433-6. PubMed ID: 20582864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 2.
    Kuhrt K
    IDrugs; 2009 Dec; 12(12):765-9. PubMed ID: 19943218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials in CNS--SMi's eighth annual conference.
    Kirk R
    IDrugs; 2010 Feb; 13(2):66-9. PubMed ID: 20127552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADMET--Fifth Annual SMi Conference.
    Comer JE
    IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and Progress in Drug Design - SMi's ninth annual meeting.
    Welchman R
    IDrugs; 2010 Apr; 13(4):239-42. PubMed ID: 20373252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical opinion leaders conflict of interests: effects of disclosures on the trust of the public and general practitioners].
    Chakroun R; Milhabet I
    Rev Epidemiol Sante Publique; 2011 Aug; 59(4):233-42. PubMed ID: 21757308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on.
    Sismondo S
    J Law Med Ethics; 2013; 41(3):635-43. PubMed ID: 24088154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New contract recommendations for physicians cooperating with the pharmaceutical industry? The "FS Codex" and its consequences for physicians].
    Häser I; Hofmann A
    Orthopade; 2005 Mar; 34(3):263-4, 266. PubMed ID: 16247838
    [No Abstract]   [Full Text] [Related]  

  • 16. International Generic Pharmaceutical Alliance - 12th Annual Conference. Part 1.
    Kuhrt K; Chace-Ortiz M
    IDrugs; 2009 Dec; 12(12):760-4. PubMed ID: 19943217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sunshine on KOLs: assessment of the nature, extent and evolution of financial ties between the leaders of professional medical associations and the pharmaceutical industry in France from 2014 to 2019: a retrospective study.
    Clinckemaillie M; Scanff A; Naudet F; Barbaroux A
    BMJ Open; 2022 Feb; 12(2):e051042. PubMed ID: 35110312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of the pharmaceutical industry on treatment guidelines].
    Smulders YM; Thijs A
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2429-31. PubMed ID: 18064860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician-Industry Financial Relationships, Key Opinion Leader Status, and Program Visibility.
    Horstman AA; Niziol LM; Shedden K; Chimonas S; Lichter PR
    Ophthalmology; 2022 Apr; 129(4):463-465. PubMed ID: 34637855
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
    Walker G
    IDrugs; 2009 Nov; 12(11):673-4. PubMed ID: 19844848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.